Haemophilus influenzae
Background
- Gram negative coccobacillus
- Facultative anaerobe
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014
Management
Antibiotic Dosing
- Rifampin <1 mo; 10mg/kg PO/IV q24h x4 days; Max: 600 mg/day; 1+ mo; 20 mg/kg PO/IV q24h x4 days; Max: 600 mg/day